A Study of Bomedemstat (MK-3543) in Participants With Mild or Moderate Hepatic Impairment (MK-3543-023)

Recruiting

Phase 1

BomedemstatA Study of Bomedemstat (MK-3543) in Participants With Mild or Moderate Hepatic Impairment (MK-3543-023)

Sponsor:

Merck Sharp & Dohme LLC

Code:

NCT07049939

Conditions

Hepatic Insufficiency

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Accepted

Interventions

Bomedemstat

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-04-08. This information was provided to ClinicalTrials.gov by Merck Sharp & Dohme LLC on 2026-01-09.